skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The use of calcium and vitamin D in the management of osteoporosis

Review

(2798) Views  (1376) Full article downloads

Authors: John A Sunyecz

Published Date September 2008 Volume 2008:4(4) Pages 827 - 836
DOI: http://dx.doi.org/10.2147/TCRM.S3552

John A Sunyecz

MenopauseRx, Inc., Uniontown, PA, USA

Abstract: Osteoporosis poses a significant public health issue, causing significant morbidity and mortality. Calcium and vitamin D utilization in the optimization of bone health is often overlooked by patients and health care providers. In addition, the optimal standard of care for osteoporosis should encompass adequate calcium and vitamin D intake. Dietary intake or supplementation with calcium and vitamin D will be reviewed, including recent recommendations for increased vitamin D intake. Compliance to calcium and vitamin D therapy is paramount for effective prevention of osteoporotic fractures. A recently released algorithm (FRAX) estimating absolute fracture risk allows the health care provider to decide when pharmacologic therapy is warranted in addition to calcium and vitamin D. When pharmacologic therapy is advised, continued use of calcium and vitamin D is recommended for optimal fracture risk reduction. A ‘bricks and mortar’ analogy is often helpful when counseling patients and this analogy will be explained. This manuscript reviews relevant data related to calcium and vitamin D use for patients at risk for fracture due to bone loss.

Keywords: osteoporosis, calcium, vitamin D, osteopenia, hip fracture, bone






 

Other articles by Dr John Sunyecz



Readers of this article also read:

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
Differences between the bisphosphonates for the prevention and treatment of osteoporosis
AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
Fospropofol disodium injection for the sedation of patients undergoing colonoscopy
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki
Bazedoxifene for the prevention of postmenopausal osteoporosis
Management of glucocorticoids-induced osteoporosis: role of teriparatide
Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
Zoledronic acid infusion for prevention and treatment of osteoporosis
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures